Search the web
Welcome, Guest
[Sign Out, My Account]
EDGAR_Online

Insider Filings - PAPADOPOULOS STELIOS
Last Updated 
14-Jun-16
Enter symbol:
symbol lookup

 

EDGAR Online: Get a Free Trial to EDGAR Online Premium | Full text Search

PAPADOPOULOS STELIOS: Declared Holdings
Company/RelationshipReportedShares  Ownership
Biogen Inc.
Director
NasdaqGS:BIIB
(historical quotes, profile, other insiders)
8-Jun-16
27-Jul-15
18,170
   10,000
28,170
  Direct
  Indirect  
  Total
Exelixis, Inc.
Director
NasdaqGS:EXEL
(historical quotes, profile, SEC, other insiders)
4-Jan-161,228,471  Direct
Regulus Therapeutics Inc.
Director
NasdaqGM:RGLS
(historical quotes, profile, other insiders)
7-Aug-15200,677  Direct

Insider & restricted shareholder transactions reported over the last two years
DateSharesStockTransaction
8-Jun-16 1,590BIIB Acquisition (Non Open Market) at $0 per share.
4-Jan-16 15,071EXEL Acquisition (Non Open Market) at $0 per share.
7-Aug-15 50,677RGLS Option Exercise at $0.38 - $2.66 per share.
27-Jul-15 *10,000BIIB Purchase at $304.78 - $304.98 per share.
(Cost of about $3,049,000)
10-Jun-15 1,040BIIB Acquisition (Non Open Market) at $0 per share.
12-Dec-14 150,000RGLS Option Exercise at $0.38 - $0.38 per share.
(Cost of about $57,000)
14-Oct-14 69,444EXEL Acquisition (Non Open Market) at $0 per share.

 

 

 

    * Indicates that some (or all) shares are held indirectly (e.g. in a trust, by a spouse, etc.)



EDGAR Online: Get a Free Trial to EDGAR Online Premium | Full text Search


Copyright © 2016 Yahoo! Inc. All rights reserved. Privacy Policy - Terms of Service
Data and information are provided by EDGAR Online, Inc. for informational purposes only and not intended for trading purposes. Yahoo!, EDGAR Online, Inc. shall have no liability for the accuracy of the information furnished or for delays, omissions or opinions expressed therein. You may not use the information for any illegal purpose or furnish the information to any person, firm, or branch office for commercial re-use or re-sale.

Questions or Comments?